PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Taiwan

National Taiwan University Hospital, Taipei